Status:
RECRUITING
Transcranial Magnetic Stimulation in Misophonia
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Misophonia
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The purpose of the project is to assess the efficacy of parietal transcranial magnetic stimulation in misophonia. N=60 participants will undergo two transcranial magnetic stimulation sessions: one inh...
Eligibility Criteria
Inclusion
- Hypersensitive to presence of a specific sound, which may be accompanied by irritation, anger/outbursts, or fear.
- Must be between the ages of 18 - 55.
- Must be fluent in English since the study's instructions, surveys, and tasks will be in English.
Exclusion
- Axis I Psychiatric condition, past or present, as defined in DSM-V.
- Disability or medical condition that prohibits completion of study. Participants must be able to complete all study procedures to ensure optimal conditions for data analysis.
- Central Nervous System (CNS) disease, such as history of brain abnormalities (e.g., neoplasms, subarachnoid cysts), cerebrovascular disease, infectious disease (e.g., abscess), or other neurological diseases, history of head trauma (defined as loss of consciousness\>3 min), or history of seizures without a resolved etiology. CNS disease and drugs that act in the peripheral or central nervous system are likely to have effects on patterns of neural activity.
- Recent or regular use of psychotropic medication (e.g., amitriptyline for migraines).
- Recent use of drugs of abuse.
- Presence of any mental implants in the head.
- Pregnant or lactating.
Key Trial Info
Start Date :
September 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06960083
Start Date
September 2 2025
End Date
June 30 2026
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai West
New York, New York, United States, 10022